NIH-funded research R37 grant

Understanding how prions and amyloid proteins damage brain cells

Official title: Mechanisms of Prion Spread and Neuronal Toxicity

Funded at University of California, San Diego · NIH-11040292 · Data updated 2026-11-12

This study is looking at how certain proteins, like prions and amyloid-beta, harm brain cells in diseases such as Alzheimer's, and it aims to find new ways to help patients by understanding how these proteins affect brain function.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2027
Funding year2025
Award (this year)$632,199
NIH project number5R37NS076896-13
Project IDNIH-11040292 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those exhibiting early signs of cognitive decline.

Less likely to help

Patients with non-neurodegenerative conditions or those without cognitive impairment may not benefit from this research.

What this research studies

This research investigates the mechanisms by which prions and amyloid-beta proteins contribute to brain cell damage and dysfunction in diseases like Alzheimer's. The team will study how certain proteins are processed and cleared in the brain, focusing on a pathway known as ESCRT that is crucial for maintaining healthy synaptic function. By using advanced techniques such as electrophysiology and microscopy, they aim to uncover the cellular changes that occur during disease progression, which could lead to new therapeutic strategies. Patients may benefit from insights gained into the underlying causes of their conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of Alzheimer's disease and related conditions.

How similar studies have gone: Previous research has shown promising results in understanding the role of protein aggregation in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Sigurdson, Christina — University of California, San Diego
  • Study coordinator: Sigurdson, Christina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.